Names and pronunciation
(se-jes′ter-one/eth′in-il es-tra- dye′ole) Annovera
PDF page 1198
Drug reference
(se-jes′ter-one/eth′in-il es-tra- dye′ole) Annovera
PDF page 1198
Func. class.: Contraceptive, estro- gen/progestin combination
PDF page 1198
USES: To prevent pregnancy in females of reproductive potential
PDF page 1198
CONTRAINDICATIONS: Hyper- sensitivity to segesterone, ethinyl estradiol, or any component; breast cancer, estrogen/ progestin-sensitive cancers, liver tumors, acute hepatitis, severe (decompensated) cirrhosis, undiagnosed abnormal uterine bleeding; use of ombitasvir/paritaprevir/ ritonavir, with or without dasabuvir, high risk of arterial/venous thrombotic diseases, migraine headaches if >35 yr of age, hyper- tension (uncontrolled), subacute bacterial endocarditis, females >35 yr who smoke
PDF page 1198
Black Box Warning: Tobacco smoking
PDF page 1198
DOSAGE AND ROUTES Contraception • Adult: Females: Vaginal: Insert 1 ring vaginally, ring should remain in place for 21 days, then removed for 7 days. One ring provides contraception for 13 cycles (1 yr)
PDF page 1198
Available forms: Vaginal ring 103 mg/17.4 mg
PDF page 1198
• Adult: Females: Vaginal: Insert 1 ring vaginally, ring should remain in place for 21 days, then removed for 7 days. One ring provides contraception for 13 cycles (1 yr)
PDF page 1198